These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5443653)

  • 21. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.
    Perry R; Campbell M; Adams P; Lynch N; Spencer EK; Curren EL; Overall JE
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):87-92. PubMed ID: 2914841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological consequences of psychotropic drug withdrawal in schizophrenic children.
    Polizos P; Engelhardt DM; Hoffman SP; Waizer J
    J Autism Child Schizophr; 1973; 3(3):247-53. PubMed ID: 4800390
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-dose treatment strategies.
    Van Putten T; Marder SR
    J Clin Psychiatry; 1986 May; 47 Suppl():12-6. PubMed ID: 2871010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of psychedelic agents with autistic schizophrenic children.
    Mogar RE; Aldrich RW
    Behav Neuropsychiatry; 1969 Nov; 1(8):44-50. PubMed ID: 5374546
    [No Abstract]   [Full Text] [Related]  

  • 26. Imipramine in preschool autistic and schizophrenic children.
    Campbell M; Fish B; Shapiro T; Floyd A
    J Autism Child Schizophr; 1971; 1(3):267-82. PubMed ID: 5172531
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 29. Acutely disturbed psychotic patients treated with parenteral haloperidol.
    Firling RJ
    IMJ Ill Med J; 1978 Feb; 153(2):117. PubMed ID: 24024
    [No Abstract]   [Full Text] [Related]  

  • 30. Granulocytopenia in children after phenothiazine therapy.
    Shabry F; Wolk JA
    Am J Psychiatry; 1980 Mar; 137(3):374-5. PubMed ID: 6101935
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy of childhood psychoses].
    Colomb G
    Rev Neuropsychiatr Infant; 1967; 15(1):95-107. PubMed ID: 6076967
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
    Karkalas Y
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873
    [No Abstract]   [Full Text] [Related]  

  • 33. The vicissitudes of aggression in normal development, in childhood neurosis and in childhood psychosis.
    Frijling-Schreuder EC
    Int J Psychoanal; 1972; 53(2):185-90. PubMed ID: 5057062
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and biological effects of fluphénazine décanoate. 35 cases].
    Borenstein P; Dumaine A; Cujo P
    Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rapid and megadose neuroleptic therapy. Critical review].
    de Girolamo G
    Minerva Psichiatr; 1985; 26(4):323-6. PubMed ID: 2869395
    [No Abstract]   [Full Text] [Related]  

  • 36. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
    Escobar JI; Barron A; Kiriakos R
    J Clin Psychopharmacol; 1983 Dec; 3(6):359-62. PubMed ID: 6139394
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR; Lavallee B
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract]   [Full Text] [Related]  

  • 38. [On psychosis and schizophrenia in childhood. Autistic and symbiotic psychoses in early childhood].
    Mahler MS
    Psyche (Stuttg); 1967 Dec; 21(12):895-914. PubMed ID: 5585653
    [No Abstract]   [Full Text] [Related]  

  • 39. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of high doses of fluphenazine in the treatment of psychotic patients.
    Faleni RA
    Psychosomatics; 1970; 11(5):496-9. PubMed ID: 5470678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.